<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01984567</url>
  </required_header>
  <id_info>
    <org_study_id>NL40392.068.12 / METC 12-3-047</org_study_id>
    <nct_id>NCT01984567</nct_id>
  </id_info>
  <brief_title>Vitamin E or Lipoic Acid on Serum Oxyphytosterol Concentrations</brief_title>
  <official_title>The Effects of Consumption of Vitamin E or Lipoic Acid on Serum Oxyphytosterol Concentrations in Subjects With Impaired Glucose Tolerance or Type II Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background of the study:

      We now know that plant sterols can oxidize, which results in the formation of
      oxyphytosterols. Animal studies have suggested that oxyphytosterols are atherogenic
      components, however this relation has not yet been studied in humans. In our previous study
      (METC 09-3-088) we have shown in healthy volunteers that serum oxyphytosterol concentrations
      are linked to oxidative stress status (i.e. we were able to identify high and low sterol
      oxidizers). From the literature is known that especially type II diabetics and IGT subjects
      are characterized by increased oxidative stress markers and reduced antioxidant capacity. For
      this reason we also want to evaluate the oxyphytosterol concentrations in this population.
      Moreover, we know propose to evaluate the effect of antioxidant supplementation, i.e. vitamin
      E or lipoic acid, on serum oxyphytosterol concentrations in type II diabetic patients. If
      possible to lower oxyphytosterol concentrations in these populations this is obviously
      beneficial in case oxyphytosterols turn out to be atherogenic. The major objective of the
      present study is to examine the effect of consuming vitamin E (804 mg) or lipoic acid (600
      mg) for 4 weeks on fasting oxyphytosterol concentrations in subjects with impaired glucose
      tolerance or type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma oxyphytosterol concentrations</measure>
    <time_frame>Measured after 4 weeks intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum lipoprotein concentrations</measure>
    <time_frame>Measured after 4 weeks intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers reflecting oxidative stress</measure>
    <time_frame>Measured after 4 weeks intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers reflecting antioxidant capacity</measure>
    <time_frame>Measured after 4 weeks intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lipoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>Daily consumption of vitamin E capsules, 3 capsules of 268 mg daily, in total daily consumption of 804 mg</description>
    <arm_group_label>Vitamin E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lipoic acid</intervention_name>
    <description>Daily consumption of lipoic acid capsules, 3 capsules of 200 mg daily, in total daily consumption of 600 mg</description>
    <arm_group_label>Lipoic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Daily consumption of 3 placebo capsules</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 18 and 75 years

          -  Body Mass Index (BMI) between 20-35 kg/m2

          -  Mean serum total cholesterol &lt;8.0 mmol/L

          -  Mean serum triacylglycerol &lt;3.0 mmol/L

          -  Diagnosed with diabetes mellitus type 2 on a clinical basis or impaired glucose
             tolerance (defined as blood glucose &gt;7.8 mmol/l and &lt;11.0 mmol/L, two hours after
             ingesting 75 gram glucose in 150 ml water)

        Exclusion Criteria:

          -  Unstable body weight (weight gain or loss &gt; 3 kg in the past two months)

          -  Active cardiovascular diseases like congestive heart failure or recent (&lt;6 months)
             event (acute myocardial infarction, cerebral vascular incident)

          -  Severe medical conditions that might interfere with the study such as epilepsy,
             asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and
             rheumatoid arthritis

          -  Use of medication such as corticosteroids, diuretics or lipid lowering therapy

          -  Use of insulin therapy

          -  Abuse of drugs or alcohol (&gt;21 units per week)

          -  Not willing to stop the consumption of vitamin supplements, containing lipoic acid
             and/or vitamin E, 1 month before the start of the study (wash-in period)

          -  Use of an investigational product within another biomedical study within the previous
             month

          -  Pregnant or breast-feeding women

          -  Current smoker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jogchum Plat, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229 ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2013</study_first_submitted>
  <study_first_submitted_qc>November 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2013</study_first_posted>
  <last_update_submitted>November 8, 2013</last_update_submitted>
  <last_update_submitted_qc>November 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Jogchem Plat</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Oxyphytosterols</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>Lipoic acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

